An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Treatment Gaining Popularity Online
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Viewers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a flourishing market exists on messaging services, where communities with numerous of participants share comparison photos, injection guides and assertions of next-day British shipping. Vendors promote the drug there before directing buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Express Concerns
However, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.
Some professionals stated the popularity for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and consumer laws, risking penalties, legal action or imprisonment.
Service Response and Content Elimination
According to TikTok, the platform has removed problematic content and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.
Online Trading Operations
Research also found groups with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of users, filled with photos of weight loss, positive testimonials and detailed guides for mixing or injecting at residence.
After moments of entering one group, a seller shared contact information, where the majority of purchases occur. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, health issues or previous experience.
Item Information and Costs
Inside these groups, messages display black plastic packages with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for Telegram stated it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering materials they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.
Her team has already seen individuals harmed by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to potentially serious health risks”.
